Clinical application of direct renin inhibitor aliskiren in combined therapy of patients with arterial hypertension and metabolic syndrome

Cover Page

Abstract


The article presents the results of clinical application of direct renin inhibitor aliskiren in combination therapy in patients with arterial hypertension and obesity. The antihypertensive efficacy of aliskiren in combination with valsartan was demonstrated as dose-dependent, and was well tolerated and high safety of this combination therapy.

About the authors

O V Dralova

I.M. Sechenov MMA

Кафедра клинической фармакологиии пропедевтики внутренних болезней; ММА им. И.М. Сеченова; I.M. Sechenov MMA

M L Maximov

I.M. Sechenov MMA

Кафедра клинической фармакологиии пропедевтики внутренних болезней; ММА им. И.М. Сеченова; I.M. Sechenov MMA

A S Ermolaeva

I.M. Sechenov MMA

Кафедра клинической фармакологиии пропедевтики внутренних болезней; ММА им. И.М. Сеченова; I.M. Sechenov MMA

References

Statistics

Views

Abstract - 628

PDF (Russian) - 42

Cited-By



Copyright (c) 2010 Дралова О.В., Максимов М.Л., Ермолаева А.С.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies